Sekandarzad, Asieb
Weber, Enya
Prager, Eric Peter
Graf, Erika
Bettinger, Dominik
Wengenmayer, Tobias
Supady, Alexander https://orcid.org/0000-0003-4056-3652
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 27 October 2021
Accepted: 2 March 2022
First Online: 18 March 2022
Change Date: 15 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-022-06267-z
Declarations
:
: This study protocol is approved by the University of Freiburg’s Ethics Committee (EK-FR 21-1470).
: Not applicable.
: ASu received speakers’ honoraria from CytoSorbents, the manufacturer of the CytoSorb device. ASu also received an unrestricted research grant from CytoSorbents. DB received speakers’ honoraria from Bayer Healthcare and the Falk Foundation. Further, he receives consulting honoraria from Bayer Healthcare, Boston Scientific, and Shionogi. EP received consulting honoraria from Novartis Pharma. EG receives consulting honoraria from Roche Pharma AG.